Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
Universal Ibogaine Inc. holds a significant position over the OTC market with its greater difference between the lower and higher ranges of trading, which is $0.0258-$0.1143 in the last 52 weeks.
Universal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of 138 K+ in the last 50 days . The average volume of the company in the last 10 days is $88.98K with $190.74M share outstanding. The stock price when the market opened was $0.05
Universal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF. In the last 52 weeks the range of the lower and upper price is $0.0258-$0.1143.
Our mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery. While seeking to move Ibogaine through Clinical Trials in Canada, we are building a network of holistic recovery clinics and a state of the art treatment program centred around new treatment modalities.
Not a trading call but all banks at very crucial levels. Kotak bank at very strong demand zone need to watch out how will this work this time. Near resistance at 1700 if it starts trading above 1700 will be a good sign. If goes down below 1640 possibility to go down further. Next support level 1500. HDFC BANK already showed weak signal Near resistance 1350....
BEL Picture perfect setup for short Sell Symmetrical triangle at verge of Break down. Two ways to play can short now @228 and add more shorts after confirmation. or wait for break down below triangle. Stop loss if closing again inside triangle It's a swing to positional trade for positional targets are big. Positional Target - 205 Swing Target -...
Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic brainstem injury, traumatic brain injury, and peripheral nerve injury are all examples of traumatic injuries and many more
$IBO stock ticker to Universal Ibogaine a company that provides ibogaine addiction treatment to patients tormented from opioid addiction in Canada is currently trading swiftly at $0.03734 with an evident hike.
Blue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
It gives UI great pleasure to announce that Nick Karos, CEO, will speak at the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond. On June 27, 2022, a hybrid online and offline event will take place. "H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance...
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
Good bounce from the support level and about to break out from 4 months of consolidation. SRT - level is also bouncing from 0.7 levels to 1.0 The past couple of days - strong committed volume with Effort move Up can be seen. ADX is rising, just out of Squeeze. Closed Bullish Engulfing The weekly trend is turned from -ve to +ve. Daily Close above 20-SMA...
UI is developing an advanced holistic addiction treatment protocol, at its Kelburn Recovery Centre, that when combined with the planned ibogaine detox methodology is expected to transform the way we treat addiction and dramatically promote the welfare of families affected by addiction.
The UI story will be distributed through numerous platforms and audiences by Blue Digital. The expected outcome is increased knowledge of UI's plans to conduct research into the use of ibogaine as part of a continuum of care for opioid addiction and other addictions.
Excellence and IBO always go hand in hand when it comes to proving its potential in the market and leaving competitors way behind the bar. The shares are trading live at $0.05 with a significant spike
The volume of $IBOGF is increasing day by day. In the last 30 days the average volume of $IBOGF has been recorded to be $4.42K.
Universal Ibogaine Inc. is going to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest.